Remedy Entertainment Oyj (HEL:REMEDY)

Remedy Entertainment Oyj Statistics

Total Valuation

HEL:REMEDY has a market cap or net worth of EUR 202.12 million. The enterprise value is 192.11 million.

Market Cap	202.12M
Enterprise Value	192.11M

Important Dates

The last earnings date was Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	n/a

Share Statistics

HEL:REMEDY has 15.69 million shares outstanding. The number of shares has increased by 0.56% in one year.

Current Share Class	15.69M
Shares Outstanding	15.69M
Shares Change (YoY)	+0.56%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	39.08%
Owned by Institutions (%)	7.22%
Float	5.50M

Valuation Ratios

The trailing PE ratio is 273.80.

PE Ratio	273.80
Forward PE	n/a
PS Ratio	3.38
PB Ratio	2.91
P/TBV Ratio	3.54
P/FCF Ratio	17.42
P/OCF Ratio	43.85
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.90, with an EV/FCF ratio of 16.56.

EV / Earnings	300.65
EV / Sales	3.21
EV / EBITDA	20.90
EV / EBIT	104.24
EV / FCF	16.56

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.25.

Current Ratio	3.93
Quick Ratio	3.93
Debt / Equity	0.25
Debt / EBITDA	1.91
Debt / FCF	1.51
Interest Coverage	1.44

Financial Efficiency

Return on equity (ROE) is 0.95% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	0.95%
Return on Assets (ROA)	1.23%
Return on Invested Capital (ROIC)	1.47%
Return on Capital Employed (ROCE)	2.13%
Revenue Per Employee	155,405
Profits Per Employee	1,660
Employee Count	367
Asset Turnover	0.64
Inventory Turnover	n/a

Taxes

In the past 12 months, HEL:REMEDY has paid 988,000 in taxes.

Income Tax	988,000
Effective Tax Rate	60.73%

Stock Price Statistics

The stock price has decreased by -2.42% in the last 52 weeks. The beta is 1.05, so HEL:REMEDY's price volatility has been similar to the market average.

Beta (5Y)	1.05
52-Week Price Change	-2.42%
50-Day Moving Average	13.61
200-Day Moving Average	14.78
Relative Strength Index (RSI)	42.21
Average Volume (20 Days)	8,947

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HEL:REMEDY had revenue of EUR 59.83 million and earned 639,000 in profits. Earnings per share was 0.05.

Revenue	59.83M
Gross Profit	45.69M
Operating Income	1.84M
Pretax Income	1.63M
Net Income	639,000
EBITDA	7.81M
EBIT	1.84M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 27.56 million in cash and 17.55 million in debt, giving a net cash position of 10.01 million or 0.64 per share.

Cash & Cash Equivalents	27.56M
Total Debt	17.55M
Net Cash	10.01M
Net Cash Per Share	0.64
Equity (Book Value)	69.57M
Book Value Per Share	5.10
Working Capital	31.91M

Cash Flow

In the last 12 months, operating cash flow was 4.61 million and capital expenditures 7.00 million, giving a free cash flow of 11.60 million.

Operating Cash Flow	4.61M
Capital Expenditures	7.00M
Free Cash Flow	11.60M
FCF Per Share	0.74

Margins

Gross margin is 76.36%, with operating and profit margins of 3.08% and 1.07%.

Gross Margin	76.36%
Operating Margin	3.08%
Pretax Margin	2.72%
Profit Margin	1.07%
EBITDA Margin	13.06%
EBIT Margin	3.08%
FCF Margin	19.39%

Dividends & Yields

HEL:REMEDY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.56%
Shareholder Yield	-0.56%
Earnings Yield	0.32%
FCF Yield	5.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HEL:REMEDY has an Altman Z-Score of 5.74 and a Piotroski F-Score of 7.

Altman Z-Score	5.74
Piotroski F-Score	7